JP2001026542A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001026542A5 JP2001026542A5 JP1999198151A JP19815199A JP2001026542A5 JP 2001026542 A5 JP2001026542 A5 JP 2001026542A5 JP 1999198151 A JP1999198151 A JP 1999198151A JP 19815199 A JP19815199 A JP 19815199A JP 2001026542 A5 JP2001026542 A5 JP 2001026542A5
- Authority
- JP
- Japan
- Prior art keywords
- vitamin
- glycosyl
- blood circulation
- naringin
- hesperidin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 3
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 2
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 2
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 2
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 229940025878 hesperidin Drugs 0.000 description 2
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 2
- 229940052490 naringin Drugs 0.000 description 2
- 229930019673 naringin Natural products 0.000 description 2
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19815199A JP2001026542A (ja) | 1999-07-12 | 1999-07-12 | 血行改善性繊維構造物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19815199A JP2001026542A (ja) | 1999-07-12 | 1999-07-12 | 血行改善性繊維構造物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001026542A JP2001026542A (ja) | 2001-01-30 |
| JP2001026542A5 true JP2001026542A5 (https=) | 2006-08-24 |
Family
ID=16386319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP19815199A Withdrawn JP2001026542A (ja) | 1999-07-12 | 1999-07-12 | 血行改善性繊維構造物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2001026542A (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003041414A (ja) * | 2001-07-23 | 2003-02-13 | Hayashibara Biochem Lab Inc | 美白効果を有する衣料品 |
| US7282473B2 (en) * | 2004-09-02 | 2007-10-16 | Invista North America S.àr.l. | Binder systems for microcapsule treatments to fibers, fabrics and garments |
| JP2008248409A (ja) * | 2007-03-29 | 2008-10-16 | Daiwabo Co Ltd | 繊維構造物 |
| WO2013075333A1 (zh) * | 2011-11-25 | 2013-05-30 | 浙江养生堂天然药物研究所有限公司 | 新橙皮苷的新用途 |
| KR101517875B1 (ko) * | 2014-12-17 | 2015-05-18 | 주식회사에너씨스 | 다용도 기능성 위생 솜 및 이의 제조방법 |
| US10568827B2 (en) * | 2015-09-02 | 2020-02-25 | Hayashibara Co., Ltd. | External dermal agent for reducing yellowish dullness |
| CN106149130B (zh) * | 2016-08-12 | 2019-01-01 | 山东滨州亚光毛巾有限公司 | 一种含银螯合腈纶纤维的可控抗菌毛巾及其制备方法 |
| CN111501211A (zh) * | 2020-04-17 | 2020-08-07 | 百事基材料（青岛）股份有限公司 | 茶多酚、柚皮甙或大黄素改性pp纺粘无纺布及制备方法 |
| JP2025019509A (ja) * | 2023-07-28 | 2025-02-07 | 東洋精糖株式会社 | 皮膚透過促進剤及び皮膚透過促進方法 |
-
1999
- 1999-07-12 JP JP19815199A patent/JP2001026542A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002511411A5 (https=) | ||
| DE60008372D1 (de) | Pharmazeutisch aktive verbindungen | |
| JP2003512395A5 (https=) | ||
| EE200100009A (et) | Bensimidasoolid, nende valmistamine ja kasutamineravimitena | |
| EE200200064A (et) | Arüülmetüülkarbonüülaminotiasooli derivaadid, nende valmistamine ja kasutamine vähivastaste toimeainetena | |
| PT1220856E (pt) | Compostos farmaceuticamente activos | |
| EE200000595A (et) | Toimeaine viimine kandjamaatriksisse | |
| DE60131663D1 (de) | Acylacetonitrile, deren herstellung und diese enthaltende miticide | |
| FR2790474B1 (fr) | Derives de pyridopyranoazepines, leur preparation et leur application en therapeutique | |
| JP2001026542A5 (https=) | ||
| FR2804430B1 (fr) | Derives de 4-heteroaryl-1,4-diazabicyclo[3.2.2] nonane, leur preparation et leur application en therapeutique | |
| FR2792318B1 (fr) | Derives d'indazole, leur preparation et leur application en therapeutique | |
| PT975230E (pt) | Polidextrose como agente anti-endurecimento | |
| DK1280784T3 (da) | Biologisk aktive 4H-benzo[1,4]oxazin-3-oner | |
| NO20004807L (no) | 3´,3´-N-bis-substituerte makrolid LHRH antagonister | |
| FR2815539B1 (fr) | Principe actif riche en isoflavones, son procede d'extraction et ses applications cosmetiques | |
| AU1389702A (en) | Optically active 2,5-bisaryl-delta<sup>1</sup>-pyrrolines and their use as pest control agents | |
| JP2002531135A5 (https=) | ||
| ITMI20000293A0 (it) | Derivati del 3,9-diazabiciclo [3.3.1]nonano ad attivita' analgesica | |
| IT1316400B1 (it) | Complesso integrale giogo di supporto e imbracatore. | |
| IT1307247B1 (it) | Carda, particolarmente per la preparazione di veli per tessuti nontessuti. | |
| MA26931A1 (fr) | Agent therapeutique cristallin. | |
| MXPA03000650A (es) | Compuesto farmaceuticamente activo. | |
| RU2001128736A (ru) | Способ нормализации воспроизводительной функции коров | |
| DE69941359D1 (de) | Cerebrospinal und vaskulär wirksame pharmazeutische zubereitung und verfahren zu ihrer herstellung |